Gunderson Dettmer represented Alimera Sciences on the transaction, while Sidley Austin LLP represented EyePoint Pharmaceuticals, Inc. Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company, has...
Alimera Sciences’ Acquisition of U.S. Commercial Rights to YUTIQ®
Thoma Bravo’s Acquisition of Anaplan
Gunderson Dettmer and Skadden advised Anaplan on the deal. Kirkland and Ellis and Cadwalader, Wickersham & Taft advised Thoma Bravo. Latham & Watkins represented the direct...